Interojo Co

Interojo Co ROIC

The Return on Invested Capital (ROIC) of Interojo Co (119610.KQ) as of Oct 21, 2026 is 8.24 %. In the previous year, Return on Invested Capital (ROIC) was 0.09 % — a change of 8,983.59% (higher).

ROIC

8.24 %

YoY

8,983.59%

Last updated:

Return on Invested Capital (ROIC) of Interojo Co is 2025 8.24 % . Return on Invested Capital (ROIC) of Interojo Co was 2024 0.09 % . It decreases by 8,983.59% higher compared to the previous year.

The Interojo Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
11.47 KRW
Jan 1, 2019
11.56 KRW
Jan 1, 2020
6.87 KRW
Jan 1, 2021
9.44 KRW
Jan 1, 2022
10.30 KRW
Jan 1, 2023
1.29 KRW
Jan 1, 2024
0.09 KRW
Jan 1, 2025
8.24 KRW
The Interojo Co ROIC history
YEARROICYoY
8.24 %+8,983.59%
0.09 %-92.95%
1.29 %-87.51%
10.30 %+9.11%
9.44 %+37.42%
6.87 %-40.60%
11.56 %+0.82%
11.47 %-37.93%
18.48 %-9.71%
20.47 %+32.00%
15.50 %+46.35%
10.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Return on Invested Capital (ROIC) of Interojo Co is 8.24 % in 2025.

Return on Invested Capital (ROIC) of Interojo Co changed from 0.09 % to 8.24 %, representing a 8,983.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Interojo Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Interojo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Interojo Co

All Key Metrics — Interojo Co